Previous close | 0.4500 |
Open | 0.4500 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 23.00 |
Expiry date | 2024-05-17 |
Day's range | 0.4500 - 0.4500 |
Contract range | N/A |
Volume | |
Open interest | 46 |
Investors need to pay close attention to About Alkermes (ALKS) stock based on the movements in the options market lately.
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.
Alkermes plc (Nasdaq: ALKS) today announced the presentation of research related to its psychiatry franchise products—LYBALVI® (olanzapine and samidorphan) and ARISTADA® (aripiprazole lauroxil)—at four scientific conferences this spring. These meetings take place during Mental Health Awareness Month in May, an important moment in the year to raise awareness about mental health conditions, support people living with these complex diseases, and honor the work of healthcare providers. The meetings